Recurrent Oral Cavity Squamous Cell Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16395 | Efineptakin alfa | 1 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB08875 | Cabozantinib | 2 | Active Not Recruiting | 1 |
| DB01101 | Capecitabine | 2 | Terminated | 1 |
| DB00958 | Carboplatin | 2 | Active Not Recruiting | 1 |
| DB00958 | Carboplatin | 2 | Completed | 1 |
| DB00958 | Carboplatin | 2 | Recruiting | 2 |
| DB14707 | Cemiplimab | 2 | Recruiting | 1 |
| DB14547 | Chloride ion | 2 | Completed | 1 |
| DB14547 | Chloride ion | 2 | Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Completed | 1 |
| DB00515 | Cisplatin | 2 | Recruiting | 1 |
| DB01248 | Docetaxel | 2 | Completed | 1 |
| DB00530 | Erlotinib | 2 | Completed | 1 |
| DB11743 | Ipatasertib | 2 | Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 2 |
| DB12257 | Platinum | 2 | Completed | 1 |
| DB12257 | Platinum | 2 | Recruiting | 1 |
| DB00398 | Sorafenib | 2 | Active Not Recruiting | 1 |
| DB02546 | Vorinostat | 2 | Terminated | 1 |